We are live on ! Find out more
TECH icon

Bio-Techne

556 hedge funds and large institutions have $16.2B invested in Bio-Techne in 2022 Q1 according to their latest regulatory filings, with 65 funds opening new positions, 199 increasing their positions, 209 reducing their positions, and 76 closing their positions.

New
Increased
Maintained
Reduced
Closed

269% more call options, than puts

Call options by funds: $30.2M | Put options by funds: $8.18M

8.03% more ownership

Funds ownership: 376.15%384.18% (+8%)

5% less repeat investments, than reductions

Existing positions increased: 199 | Existing positions reduced: 209

3% less funds holding

Funds holding: 575556 (-19)

14% less first-time investments, than exits

New positions opened: 65 | Existing positions closed: 76

15% less capital invested

Capital invested by funds: $19.1B → $16.2B (-$2.9B)

20% less funds holding in top 10

Funds holding in top 10: 1512 (-3)

Holders
556
Holders Change
-19
Holders Change %
-3.3%
% of All Funds
8.77%
Holding in Top 10
12
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-20%
% of All Funds
0.19%
New
65
Increased
199
Reduced
209
Closed
76
Calls
$30.2M
Puts
$8.18M
Net Calls
+$22M
Net Calls Change
+$14.6M
Name Holding Trade Value Shares
Change
Change in
Stake
EVM
101
Eaton Vance Management
Massachusetts
$16.1M +$6.16M +59,712 +67%
William Blair & Company
102
William Blair & Company
Illinois
$16.1M +$192K +1,860 +1%
Prudential Financial
103
Prudential Financial
New Jersey
$15.1M -$54.9K -532 -0.4%
Baird Financial Group
104
Baird Financial Group
Wisconsin
$14.8M -$496K -4,808 -3%
Manulife (Manufacturers Life Insurance)
105
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$14.8M -$37.1K -360 -0.3%
DWT
106
Dorsey & Whitney Trust
South Dakota
$14.4M -$42.9K -416 -0.3%
DZ Bank
107
DZ Bank
Germany
$14.3M -$2.6M -25,168 -16%
Renaissance Technologies
108
Renaissance Technologies
New York
$14M +$9.53M +92,400 +251%
SW
109
SVB Wealth
Massachusetts
$13.6M -$2.35M -22,824 -15%
FWIA
110
Fort Washington Investment Advisors
Ohio
$13.4M +$2.39M +23,120 +23%
Mariner
111
Mariner
Kansas
$13.4M +$12.7M +123,384 New
HSBC Holdings
112
HSBC Holdings
United Kingdom
$13.1M -$7.2M -69,780 -37%
PNC Financial Services Group
113
PNC Financial Services Group
Pennsylvania
$12.9M -$156K -1,512 -1%
MSV
114
MN Services Vermogensbeheer
Netherlands
$12.2M -$248K -2,400 -2%
Korea Investment Corp
115
Korea Investment Corp
South Korea
$12.2M +$8.09M +78,400 +228%
WC
116
Westwind Capital
New Mexico
$12M +$11.4M +110,964 New
DCM
117
Driehaus Capital Management
Illinois
$11.6M -$4.1M -39,720 -27%
Citigroup
118
Citigroup
New York
$11M -$886K -8,588 -8%
Man Group
119
Man Group
United Kingdom
$10.9M +$1.26M +12,208 +14%
PVI
120
Pura Vida Investments
New York
$10.8M +$10.3M +100,000 New
BNP Paribas Financial Markets
121
BNP Paribas Financial Markets
France
$10.4M -$2.5M -24,272 -20%
Chevy Chase Trust
122
Chevy Chase Trust
Maryland
$10.2M +$25.6K +248 +0.3%
SCM
123
Snyder Capital Management
California
$10.1M -$273K -2,648 -3%
TD Asset Management
124
TD Asset Management
Ontario, Canada
$9.8M -$963K -9,336 -9%
State of New Jersey Common Pension Fund D
125
State of New Jersey Common Pension Fund D
New Jersey
$9.75M

TECH Hedge Fund Activity: Q1 2022 in Review

556 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Bio-Techne (TECH) for Q1 2022, worth a combined $16.2B — down 15% from $19.1B a quarter earlier.

Sellers outnumbered buyers: 76 funds closed out of TECH and 65 opened new positions — a net loss of 11 holders — while 209 trimmed existing stakes and 199 added.

The largest buyer was Select Equity Group, opening a new position worth an estimated $288M. The largest seller was Marshall Wace, cutting an estimated $125M.

  • 556 institutional investors held Bio-Techne (TECH) as of Q1 2022, down from 575 in Q4 2021.
  • Funds reported $16.2B of Bio-Techne stock for Q1 2022, down 15% quarter-over-quarter.
  • 65 funds opened new Bio-Techne positions in Q1 2022 and 76 closed out, a net change of -11 holders.
  • The largest Bio-Techne buyer in Q1 2022 was Select Equity Group, an estimated $288M added.
  • The largest Bio-Techne seller in Q1 2022 was Marshall Wace, an estimated $125M sold.

Based on aggregated 13F filings for Q1 2022.